ProfileGDS4132 / 219055_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 21% 23% 26% 24% 24% 24% 19% 32% 31% 21% 29% 32% 32% 41% 29% 31% 30% 24% 30% 31% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10147.775921
GSM201543Muscle PCOS pioglitazone 12147.160423
GSM201544Muscle PCOS pioglitazone 16163.713326
GSM201545Muscle PCOS pioglitazone 20161.598324
GSM201829Muscle PCOS pioglitazone 23159.775724
GSM201830Muscle PCOS pioglitazon 25157.206424
GSM201831Muscle PCOS pioglitazone 27137.756719
GSM201832Muscle PCOS pioglitazone 3179.351232
GSM201833Muscle PCOS pioglitazone 4172.150531
GSM201834Muscle PCOS pioglitazone 8145.420521
GSM201835Muscle PCOS after pioglitazone 10256.353329
GSM201836Muscle PCOS after pioglitazone 12269.267432
GSM201837Muscle PCOS after pioglitazone 16264.818832
GSM201838Muscle PCOS after pioglitazone 20296.053741
GSM201839Muscle PCOS after pioglitazone 23264.550229
GSM201840Muscle PCOS after pioglitazone 25272.571631
GSM201841Muscle PCOS after pioglitazone 27259.045430
GSM201842Muscle PCOS after pioglitazone 3243.394924
GSM201843Muscle PCOS after pioglitazone 4272.831230
GSM201844Muscle PCOS after pioglitazone 8271.100431